Wei Zhou
Broad Institute(US)Hebei Medical University(CN)Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Central South University(CN)Second Military Medical University(CN)Peking University(CN)National Clinical Research Center for Digestive Diseases(CN)Second Hospital of Hebei Medical University(CN)Children's Hospital of Zhejiang University(CN)Changhai Hospital(CN)Zhuzhou Central Hospital(CN)Peking University Third Hospital(CN)Chongqing Cancer Hospital(CN)Xijing Hospital(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Gastrointestinal Bleeding Diagnosis and Treatment, Dental materials and restorations, Cancer-related molecular mechanisms research
Most-Cited Works
- → Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial(2015)1,554 cited
- → Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells(2011)253 cited
- → Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases(2016)156 cited
- → Rapidly in Situ Forming Biodegradable Robust Hydrogels by Combining Stereocomplexation and Photopolymerization(2007)155 cited
- → Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone.(1994)141 cited
- → Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab(2009)